about
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent BiosynthesisGlycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancerBariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal.Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation.Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.Akt signalling in health and disease.The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.GAM: a web-service for integrated transcriptional and metabolic network analysis.Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.Differential effects of AMPK agonists on cell growth and metabolismOverexpression of the TXNDC5 protein in non-small cell lung carcinoma.The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathwayThe energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.Effects of ulapualide A and synthetic macrolide analogues on actin dynamics and gene regulation.MELODI: Mining Enriched Literature Objects to Derive Intermediates.The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism.Influence of puberty timing on adiposity and cardiometabolic traits: A Mendelian randomisation studyAkt and STAT5 mediate naïve human CD4+ T-cell early metabolic response to TCR stimulationAssociation Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian CancerA Phenome-Wide Mendelian Randomization Study of Pancreatic Cancer Using Summary Genetic DataInterleukin-5 drives glycolysis and reactive oxygen species-dependent citric acid cycling by eosinophilsEarly Metabolic Features of Genetic Liability to Type 2 Diabetes: Cohort Study With Repeated Metabolomics Across Early Life
P50
Q28551227-B5638598-DD3B-4897-BD96-FF842377D4B4Q34654039-EEE8D2D0-0DA3-4163-9390-029AAE2AE69BQ35034550-DECB65D3-DD31-47A3-AB2A-7B2D4A063E52Q35393067-39EB94B9-0737-4839-B303-64FC7B258D80Q37412828-89DDB83F-5D96-48A7-B05B-833F0AC55831Q37599925-A8F0AEF0-C469-4FFC-BB41-601FD7E72C4CQ37881228-5434722F-1682-4390-8D93-79250D609DE9Q38184207-1F277C5B-6B0B-4249-8FEA-9D6BEC83B324Q38776754-5060E7A4-6848-487E-93F5-B80D59BD1086Q38827417-93D121E5-4C4F-4D0F-B80F-63DED1412DFEQ38954598-479DCD99-7183-4AE1-8728-088790FF1976Q39535651-600DE632-BA3A-41EA-A28F-825CB0FEC6B8Q41116146-39FA30F7-9839-4EF2-A1AF-D7C2834C4520Q41530637-76D06429-130E-4AEE-A8E8-4F3BD331C2B8Q42831311-CFCBE5B6-5C57-4C85-9A91-3C3EC076B4EDQ50000956-02040177-5990-4CFE-881E-92D71A8516D7Q51587651-3248C43F-9258-432C-81F6-EDF1A8F6F6F7Q57101467-E1BE66AD-2105-476B-8B15-80881DD508A5Q64068861-725F63D1-EEE1-4E96-877E-8C4BDAA8B35DQ89756758-1D2F2B34-798C-4942-BA7A-8AEE56FA293CQ91966830-EF613AD4-B026-442C-BE95-46C185008382Q92125232-54D4146F-B728-46C5-B5AE-749D7D20D89BQ94451645-5D805489-9CB7-4234-B7BC-0DECB10FF25A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emma E. Vincent
@ast
Emma E. Vincent
@en
Emma E. Vincent
@es
Emma E. Vincent
@nl
Emma E. Vincent
@sl
type
label
Emma E. Vincent
@ast
Emma E. Vincent
@en
Emma E. Vincent
@es
Emma E. Vincent
@nl
Emma E. Vincent
@sl
prefLabel
Emma E. Vincent
@ast
Emma E. Vincent
@en
Emma E. Vincent
@es
Emma E. Vincent
@nl
Emma E. Vincent
@sl
P106
P1153
37103013900
P21
P31
P496
0000-0002-8917-7384